Form 8-K - Current report:
SEC Accession No. 0001558370-20-009511
Filing Date
2020-08-06
Accepted
2020-08-06 08:04:56
Documents
14
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20200806x8k.htm   iXBRL 8-K 31617
2 EX-99.1 ardx-20200806xex99d1.htm EX-99.1 153559
3 GRAPHIC ardx-20200806xex99d1001.jpg GRAPHIC 6068
  Complete submission text file 0001558370-20-009511.txt   323381

Data Files

Seq Description Document Type Size
4 EX-101.SCH ardx-20200806.xsd EX-101.SCH 3271
5 EX-101.LAB ardx-20200806_lab.xml EX-101.LAB 15499
6 EX-101.PRE ardx-20200806_pre.xml EX-101.PRE 10514
7 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20200806x8k_htm.xml XML 4615
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 201079919
SIC: 2834 Pharmaceutical Preparations